Company intelligence / Profile preview

MT-MicroSearch

Ownership: Private
Development stage: Commercial

Overview

MT-MicroSearch Aps produced bacterial mixtures for fecal microbiota transplantation that were directly administered to patients in clinical research settings. In at least one published study, their product was used to treat recurrent C. difficile infection with positive outcomes reported regarding efficacy and safety compared to other interventions over long-term follow-up.[10]

Therapeutic areas: GastroenterologyInfectious Diseases
Modalities: Fecal microbiota transplant (FMT)Bacterial mixtures for therapeutic use
Industry: Biotech

Drug pipeline

1 asset

rectal bacteriotherapy

Partnerships

Not specified; likely collaborates with academic medical centers and hospitals conducting clinical trials using their products.[10]

Beyond the preview

Go deeper on MT-MicroSearch.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MT-MicroSearch.

Explore the full profile